Abiopharma

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

Tredegar Announces Bonnell Aluminum Leadership Changes

Forgent Power Solutions Announces Closing of Public Offering of Class A Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Agilysys to Participate in the William Blair 46th Annual Growth Stock Conference

Abivax annonce des résultats majeurs de l’essai de maintenance de phase 3 ABTECT évaluant l’obéfazimod dans le traitement de la rectocolite hémorragique active modérée à sévère

Central Securities Corporation Declares Dividend

New Jersey Natural Gas Submits Filings to NJBPU for Customer Savings and Future Recovery of Reliability Investments

Penguin Solutions Announces CFO Transition

HONEYWELL APPOINTS JILL EVANKO TO BOARD OF DIRECTORS

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)